A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7496-7503

  Lam, Jennifer S ^a,b   Mansour, Michael K ^a,b   Specht, Charles A ^b   Levitz, Stuart M ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FUNGUS VACCINE; MANNAN; MANNOSE RECEPTOR; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN MANNOSYLATION; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; ESCHERICHIA COLI; FUNGUS; GLYCOSYLATION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; T LYMPHOCYTE; VACCINE PRODUCTION;

EID: 28244496177     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7496     Document Type: Article

References (47)

1. Zinkernagel, R. M. 2003. On natural and artificial vaccinations. Annu. Rev. Immunol. 21: 515-546.
2. Esser, M. T., R. D. Marchese, L. S. Kierstead, L. G. Tussey, F. Wang, N. Chirmule, and M. W. Washabaugh. 2003. Memory T cells and vaccines. Vaccine 21: 419-430.
3. Engering, A. J., M. Cella, D. Fluitsma, M. Brockhaus, E. C. Hoefsmit, A. Lanzavecchia, and J. Pieters. 1997. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27: 2417-2425.
4. Hattori, Y., S. Kawakami, S. Suzuki, F. Yamashitu, and M. Hashida. 2004. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. 317: 992-999.
5. Arigita, C., L. Bevaart, L. A. Everse, G. A. Koning, W. E. Hennink, D. J. Crommelin, J. G. van de Winkel, M. J. van Vugt, G. F. Kersten, and W. Jiskoot. 2003. Liposomal merringococcal B vaccination; role of dendritic cell targeting in the development of a protective immune response. Infect. Immun. 71: 5210-5218.
6. Keler, T., V, Ramakrishna, and M. W. Fanger. 2004. Mannose receptor-targeted vaccines. Expert Opin. Biol. Ther. 4: 1953-1962.
7. Tan, M. C., A. M. Mommaas, J. W. Drijfhout, R. Jordens, J. J. Onderwater, D. Verwoerd, A. A. Mulder, A. N, van der Heiden, D. Scheidegger, L. C. Oomen, et al. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27: 2426-2435.
8. Vaughan, H. A., D. W. Ho, V. Karanikas, M. S. Sandrin, I. F. McKenzie, and G. A. Pietersz. 2000. The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan. Vaccine 18: 3297-3309.
9. Toda, S., N. Ishii, E. Okada, K. I. Kusakabe, H. Arai, K. Hamajima, I. Gorai, K. Nishioka, and K. Okuda. 1997. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody. Immunology 92: 111-117.
10. East, L., and C. M. Isacke. 2002. The mannose receptor family. Biochim. Biophys. Acta 1572: 364-386.
11. Mitchell, D. A., A. J. Fadden, and K. Drickamer. 2001. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Sub-unit organization and binding to multivalent ligands. J. Biol. Chem. 276: 28939-28945.
12. Engering, A., T. B. Geijtenbeek, S. J. van Vliet, M. Wijers, E. van Liempt, N. Demaurex, A. Lanzavecchia, J. Fransen, C. G. Figdor, V. Piguet, et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168: 2118-2126.
13. Ramakrishna, V., J. F. Treml, L. Vitale, J. E. Connolly, T. O'Neill, P. A. Smith, C. L. Jones, L. Z. He, J. Goldstein, P. K. Wallace, et al. 2004. Mannose receptor targeting of tumor antigen pme117 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J. Immunol. 172: 2845-2852.
14. Mansour, M. K., L. S. Schlesinger, and S. M. Levitz. 2002. Optimal T cell responses to Crypiococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J. Immunol. 168: 2872-2879.
15. Levitz, S. M., S. Nong, M. K. Mansour, C. Huang, and C. A. Specht. 2001. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 98: 10422-10427.
16. Huang, C., S. H. Nong, M. K. Mansour, C. A. Specht, and S. M. Levitz. 2002. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infect. Immun. 70: 5485-5493.
17. Lee, S. J., S. Evers, D. Roeder, A. F. Parlow, J. Risteli, L. Risteli, Y. C. Lee, T. Feizi, H. Langen, and M. C. Nussenzweig. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295: 1898-1901.
18. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
19. Qin, Z., G. Noffz, M. Mohaupt, and T. Blankenstein. 1997. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159: 770-776.
20. Bretthauer, R. K., and F. J. Castellino. 1999. Glycosylation of Pichia pastoris-derived proteins. Biotechnol. Appl. Biochem. 30: 193-200.
21. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
22. Apostolopoulos, V., G. A. Pietersz, B. E. Loveland, M. S. Sandrin, and I. F. McKenzie. 1995. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc. Natl. Acad. Sci. USA 92: 10128-10132.
23. Apostolopoulos, V., G. A. Pietersz, and I. F. McKenzie. 1996. Cell-mediated immune responses to MUCl fusion protein coupled to mannan. Vaccine 14: 930-938.
24. Lofthouse, S. A., V. Apostolopoulos, G. A. Pietersz, W. Li, and I. F. McKenzie. 1997. Iamucin-1nduction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to amucin-1 tumour antigen. Vaccine 15: 1586-1593.
25. Apostolopoulos, V., V. Karanikas, J. S. Haurum, and I. F. McKenzie. 1997. Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J. Immunol. 159: 5211-5218.
26. Noguchi, Y., T. Noguchi, T. Sato, Y. Yokoo, S. Itoh, M. Yoshida, T. Yoshiki, K. Akiyoshi, J. Sunamoto, E. Nakayama, et al. 1991. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome, J. Immunol. 146: 3599-3603.
27. Sugimoto, M., K. Ohishi, M. Fukasawa, K. Shikata, H. Kavvai, H. Itakura, M. Hatanaka, R. Sakakibara, M. Ishiguro, M. Nakata, et al. 1995. Oligomannosecoated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett. 363: 53-56.
28. Stubbs, A. C., K. S. Martin, C. Coeshott, S. V. Skaates, D. R. Kuritzkes, D. Hellgrau, A. Franzusoff, R. C. Duke, and C. C. Wilson. 2001. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med. 1: 625-629.
29. Duman, J. G., R. G. Miele, H. Liang, D. K. Grella, K. L. Sim, F. J. Castellino, and R. K. Bretthauer. 1998. O-mannosylation of Pichia pastoris cellular and recombinant proteins. Biotechnol. Appl. Biochem. 28: 39-45.
30. Trimble, R. B., C. Lubowski, C. R. Hauer III, R. Stack, L. McNaughton, T. R. Gemmill, and S. A. Kumar. 2004. Characterization of N- and O-linked glycosylation of recombinant human bile salt-stimulated lipase secreted by Pichia pastoris. Glycobiology 14: 265-274.
31. Gemgross, T. U. 2004. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol. 22: 1409-1414.
32. Choi, B. K., P. Bobrowicz, R. C. Davidson, S. R. Hamilton, D. H. Kung, H. Li, R. G. Miele, J. H. Nett, S. Wildt, and T. U. Gemgross. 2003. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc. Natl. Acad. Sci. USA 100: 5022-5027.
33. Hamilton, S. R., P. Bobrowicz, B. Bobrowicz, R. C. Davidson, H. Li. T. Mitchell, J. H. Nett, S. Rausch, T. A. Stadheim. H. Wischnewski, et al. 2003. Production of complex human glycoproteins in yeast. Science 301: 1244-1246.
34. Park, C. G., K. Takahara, E. Umemoto, Y. Yashima, K. Matsubara, Y. Matsuda, B. E. Clausen, K. Inaba, and R. M. Steinman. 2001. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13: 1283-1290.
35. Takahara, K., Y. Yashima, Y. Omatsu, H. Yoshida, Y. Kimura, Y. S. Kang, R. M. Steinman, C. G. Park, and K. Inaba. 2004. Functional comparison of the mouse DC-SIGN. SIGNR1, SIGNR3 and langerin. C-type lectins. Int. Immunol. 16: 819-829.
36. Takahara, K., Y. Omatsu, Y. Yashima, Y. Maeda, S. Tanaka, T. Iyoda, B. E. Clausen, K. Matsubara, J. Letterio, R. M. Steinman, et al. 2002. Identification and expression of mouse langerin (CD207) in dendritic cells. Int. Immunol. 14: 433-444.
37. Stambach, N. S., and M. E. Taylor. 2003. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology 13: 401-410.
38. McGreal, E. P., J. L. Miller, and S. Gordon. 2005. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr. Opin. Immunol. 17: 18-24.
39. Kissenpfennig, A., S. Ait-Yahia, V. Clair-Moninot, H. Stossel, E. Badell, Y. Bordat, J. L. Pooley, T. Lang, E. Prina, I. Coste, et al. 2005. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell. Biol. 25: 88-99.
40. Holzmann, S., C. H. Tripp, M. Schmuth, K. Janke, F. Koch, S. Saeland, P. Stoitzner, and N. Romani. 2004. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J. Invest. Dermatol. 122: 1165-1174.
41. Valladeau, J., V. Clair-Moninot, C. Dezutter-Dambuyant, J. J. Pin, A. Kissenpfennig, M. G. Mattel, S. Ait-Yahia, E. E. Bates, B. Malissen, F. Koch, et al. 2002. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 168: 782-792.
42. Chieppa, M., G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, et al. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171: 4552-4560.
43. Nigou, J., C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166: 7477-7485.
44. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hemandez, C. M. Vandenbroucke-Grauls, B. Appelmelk, and Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197: 7-17.
45. Nagaoka, K., K. Takahara, K. Tanaka, H. Yoshida, R. M. Steinman, S. I. Saitoh, S. Akashi-Takamura, K. Miyake, Y. S. Kang, C. G. Park, et al. 2005. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in Gram-negative bacteria. Int. Immunol. 17: 827-836.
46. Hanisch, F. G., T. Schwientek, M. S. Von Bergwelt-Baildon, J. L. Schultze, and O. Finn. 2003. O-linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUCl processing by dendritic cells. Eur. J. Immunol. 33: 3242-3254.
47. Vlad, A. M., S. Muller, M. Cudic, H. Pauken, L. Otvos, Jr., F. G. Hanisch, and O. J. Finn. 2002. Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUCl glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 196: 1435-1446.